Search Within

Maria Isabel Carlo

Formats
  1. Journal Article (80)
  2. Meeting Abstract (68)
  3. Review (8)
  4. Guidelines (4)
  5. Correspondence (2)
  6. Research Letter (2)
  7. Book Section (1)
  8. Editorial (1)
Groups
  1. Department of Medicine (166)
  2. Genitourinary Oncology Service (166)
  3. Population Sciences Research Program (166)
  4. Solid Tumor Oncology Division (166)
  5. Weinberg Fellows (166)
  6. Department of Pathology and Laboratory Medicine (104)

More Groups

People
  1. Robert Motzer (70)
  2. Martin Voss (68)
  3. Kenneth Offit (56)
  4. Chung-Han Lee (55)
  5. Zsofia Stadler (55)
  6. Darren Feldman (53)

More People

Years
  1. 2025 (10)
  2. 2024 (14)
  3. 2023 (20)
  4. 2022 (31)
  5. 2021 (24)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (53)
  2. European Urology (11)
  3. JCO Precision Oncology (9)
  4. Urologic Oncology: Seminars and Original Investigations (6)
  5. Cancer (5)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (63)
  2. Elsevier Inc. (15)
  3. Elsevier Science, Inc. (14)
  4. American Association for Cancer Research (10)
  5. Nature Publishing Group (9)
  6. Oxford University Press (9)

More Publishers

Results (166)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Medullary renal cell carcinoma (RCC): Genomics and treatment outcomes
    Meeting Abstract

    Lee, C. H.; Carlo, M.; Chen, Y.; Chaim, J.; Coskey, D.; Woo, K.; Voss, M.; Hsieh, J.; Feldman, D.; Motzer, R.
    BJU International (2016)

    Fulltext@MSK | Save
  • Genomic alterations and outcomes with targeted therapy in patients with clear cell renal cell carcinoma
    Meeting Abstract

    Carlo, M.
    BJU International (2016)

    Fulltext@MSK | Save
  • Response to nivolumab in a patient with metastatic clear cell renal cell carcinoma and end-stage renal disease on dialysis
    Journal Article

    Carlo, M. I.; Feldman, D. R.
    European Urology (2016)

    Fulltext@MSK | Save
  • Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Voss, M. H.; Motzer, R. J.
    Nature Reviews Urology (2016)

    Fulltext@MSK | Save
  • A phase Ib study of BEZ235, a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), in patients with advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Molina, A. M.; Lakhman, Y.; Patil, S.; Woo, K.; Deluca, J.; Lee, C. H.; Hsieh, J. J.; Feldman, D. R.; Motzer, R. J.; more...
    The Oncologist (2016)

    Fulltext@MSK | Save
  • Systemic bevacizumab (Bev) for leptomeningeal disease (LMD) from non-small cell lung cancer
    Meeting Abstract

    Carlo, M.; Omuro, A.; Grommes, C.; Kris, M.; Nolan, C.; Pentsova, E.; Pietanza, M.; Kaley, T.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save